Sort
82,697 grants matching “vaccine development”
CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM
$1,703,772Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2009 · RR
Role of the microbiota in immunity
$1,703,271Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
EPITHELIAL OVARIAN CANCER PROGRAM PROJECT
$1,703,177Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
Papillomavirus Virion Proteins and Vaccines
$1,702,735John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,702,601Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MEN
$1,702,389University Of California Los Angeles · U01 · FY2000 · AI
Clinical Research Support for the CCR
$1,702,120Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
KwaZulu-Natal Clinical Trials Unit
$1,702,028Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2024 · AI
UAB Center for AIDS Research
$1,701,730University Of Alabama At Birmingham · P30 · FY2005 · AI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
$1,701,287J Brooks Jackson · Social And Scientific Systems, Inc. · U01 · FY2010 · AI
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,701,222Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Influenza Vaccine Development
$1,701,158Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75
$1,700,968Sean X Leng · Johns Hopkins University · U01 · FY2024 · AI
Molecular Biology of Francisella tularensis Virulence
$1,700,631University Of Texas Sw Med Ctr/Dallas · P01 · FY2004 · AI
HIV Vaccine Design and Development, Part A-Preventative Vaccines
$1,700,000 · N01 · FY2007 · AI
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS FOR PREVENTION AND TREATMENT
$1,700,000Susan W Barnett · · N01 · FY2007 · AI
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,699,965Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2008 · AI
Immune Response Consortium: Integrated In Silico, In Vitro, and In Vivo Studies
$1,699,693Arup K. Chakraborty · Massachusetts Institute Of Technology · P01 · FY2006 · AI
Moffitt Skin Cancer SPORE
$1,699,611Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA
Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination
$1,699,333Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2014 · AI
The origin, predictors, and immune correlates of viral rebound in orally SHIV infected infant monkeys
$1,698,360Sallie R. Permar · Duke University · P01 · FY2017 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,698,242Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
DEVELOPMENT OF NOVEL VACCINES AND THERAPEUTICS USING PLANT-BASED EXPRESSION SYSTEMS
$1,698,000Owensboro Health Regional Hospital · · FY2009 · Department of the Army
Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.
$1,697,948Jonathan Smith · Alphavax Human Vaccines, Inc. · U01 · FY2007 · AI
Miami Womens Interagency HIV Study WIHS
$1,697,885Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2018 · AI